[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cell Based Assay Market, 2012 to 2023

January 2018 | 196 pages | ID: CDC29FACBA2EN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Cell Based Assay Market is increased at a significant CAGR owing to rise in funding and investment for the R&D activities. Increase in the prevalence and incidence of chronic diseases such as cancer, drug discovery, increase in the government expenditure, and rise in the adoption of cell-based consumables by various organizations might fuel the cell-based assay market over the forecast period. Moreover, the rise in demand for biological drugs, increase the preference for toxicity screening in drugs, and reduction of cost associated with the drug discovery expected to boost the cell based assay market. However, lack of skilled professionals for conducting the cell based assays, the high cost of the instruments, and stringent regulatory policies might hinder the growth of cell based Assay market.

Market Outline: Global Cell Based Assay Market

Cell based Assay is the analytical techniques to determine the different parameters such as biochemical or cellular functions of a living cell. Cell based Assay is used in the research of new drugs by using functional cells as diagnostic tools. The cell based Assay is commonly used to measure motility, toxicity, cell proliferation, enzyme activity, and morphology in the diagnostics and drug discovery. Cell based Assay is carried in several therapeutic areas such as cancer, stem cells, immunology, and others.

Cell based assay market segmented based on the product type, application, and end user

Based on the product type, cell based assay market segmented into the following:

Consumables
Assay Kits
Reagents
Cell growth assay
Reporter gene assay
Immortalized cell lines
Stem cell lines
Primary cell lines
Others

Based on the application, cell based assay market segmented into the following:

ADME studies
Basic research
Predictive toxicology
Drug discovery
Other

Based on the end user, cell-based Assay market segmented into the following

Diagnostic Centres
Hospitals
Biopharmaceutical companies
Contract research organizations

The cell based assay market is in developing stage owing to increase in research and development for new drugs. Increase in the prevalence of various cancer diseases and immunological disorders also expected to propel the market growth. Collaborations, acquisitions & merging, and launch of new products are some of the key strategies followed by the players to increase market share. For instance, in November 2016, Axiogenesis collaborated with Metrion Biosciences Ltd to optimise, validate, and commercialize iPSC derived cell-based Assay for the new drug discovery. Investment from various companies for the R&D activities and entry of start-up companies into the market also bolster the cell based assay market growth.

Geographically, cell based assay market is segmented into, Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America expected to hold a major share in cell based assay market owing to increase in the prevalence of chronic diseases such as cancer, a rise in funding for the R&D activities, developed healthcare infrastructure, and innovation of novel drugs might propel the market growth. Europe holds a significant share in cell based assay market attributed to increase in the prevalence of chronic diseases such as cancer and immune disorders, change in lifestyle, increased healthcare expenditure, an increase in the focus of biopharmaceutical companies on the innovation of new products. Asia Pacific region is expected to grow at a significant rate due to increased investment by pharmaceutical companies, a rise in healthcare expenditure, an increase in the development of new drugs might bolster the cell based assay market over the forecast timeframe.

Some of the players in cell based assay market are PerkinElmer Inc. (U.S.), GE Healthcare (U.K), ProQinase GmbH (Germany), Danaher Corporation (U.S.), Essen BioScience Inc. (U.S.), Lonza Group (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abenex Capital SA (France), Axiogenesis AG (Germany), and Metrion Biosciences Ltd. (U.K.) to name a few.

In July 2016, Abenex acquired the Cisbio BioAssay from Argos Soditic for developing its product portfolio
1. EXECUTIVE SUMMARY

2. GLOBAL CELL BASED ASSAY MARKET INTRODUCTION

2.1. Global Cell Based Assay Market – Taxonomy
2.2. Global Cell Based Assay Market –Definitions
  2.2.1. Product Type
  2.2.2. Application
  2.2.3. End-User

3. GLOBAL CELL BASED ASSAY MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Cell Based Assay Market Dynamics – Factors Impact Analysis
3.6. Global Cell Based Assay Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe

4. GLOBAL CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL CELL BASED ASSAY MARKET, BY PRODUCT TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Consumables
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Assay Kits
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis
5.3. Reagents
  5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.3.3. Market Opportunity Analysis
5.4. Cell growth assay
  5.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.4.3. Market Opportunity Analysis
5.5. Reporter gene assay
  5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.5.3. Market Opportunity Analysis
5.6. Immortalized cell lines
  5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.6.3. Market Opportunity Analysis
5.7. Stem cell lines
  5.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.7.3. Market Opportunity Analysis
5.8. Primary cell lines
  5.8.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.8.3. Market Opportunity Analysis
5.9. Others
  5.9.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.9.3. Market Opportunity Analysis

6. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY APPLICATION TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. ADME studies
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. Basic research
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. Predictive toxicology
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. Drug discovery
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. Other
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis

7. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. Diagnostic Centres
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Hospitals
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Biopharmaceutical companies
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis
7.4. Contract research organizations
  7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.4.3. Market Opportunity Analysis

8. GLOBAL CELL BASED ASSAY MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. North America
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Europe
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Asia-Pacific
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis
8.4. Latin America
  8.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.4.3. Market Opportunity Analysis
8.5. Middle East and Africa
  8.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.5.3. Market Opportunity Analysis
8.6. Global Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User, and Region, 2017 – 2023

9. NORTH AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  9.1.1. Consumables
  9.1.2. Assay Kits
  9.1.3. Reagents
  9.1.4. Cell growth assay
  9.1.5. Reporter gene assay
  9.1.6. Immortalized cell lines
  9.1.7. Stem cell lines
  9.1.8. Primary cell lines
  9.1.9. Others
9.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.2.1. ADME studies
  9.2.2. Basic research
  9.2.3. Predictive toxicology
  9.2.4. Drug discovery
  9.2.5. Other
9.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  9.3.1. Diagnostic Centres
  9.3.2. Hospitals
  9.3.3. Biopharmaceutical companies
  9.3.4. Contract research organizations
9.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  9.4.1. U.S.
  9.4.2. Canada
9.5. North America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
9.6. North America Cell Based Assay Market Dynamics – Trends

10. EUROPE CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Consumables
  10.1.2. Assay Kits
  10.1.3. Reagents
  10.1.4. Cell growth assay
  10.1.5. Reporter gene assay
  10.1.6. Immortalized cell lines
  10.1.7. Stem cell lines
  10.1.8. Primary cell lines
  10.1.9. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. ADME studies
  10.2.2. Basic research
  10.2.3. Predictive toxicology
  10.2.4. Drug discovery
  10.2.5. Other
10.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. Diagnostic Centres
  10.3.2. Hospitals
  10.3.3. Biopharmaceutical companies
  10.3.4. Contract research organizations
10.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Germany
  10.4.2. UK
  10.4.3. France
  10.4.4. Spain
  10.4.5. Italy
  10.4.6. Russia
  10.4.7. Poland
  10.4.8. Rest of Europe
10.5. Europe Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
10.6. Europe Cell Based Assay Market Dynamics – Trends

11. ASIA-PACIFIC CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Consumables
  11.1.2. Assay Kits
  11.1.3. Reagents
  11.1.4. Cell growth assay
  11.1.5. Reporter gene assay
  11.1.6. Immortalized cell lines
  11.1.7. Stem cell lines
  11.1.8. Primary cell lines
  11.1.9. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. ADME studies
  11.2.2. Basic research
  11.2.3. Predictive toxicology
  11.2.4. Drug discovery
  11.2.5. Other
11.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. Diagnostic Centres
  11.3.2. Hospitals
  11.3.3. Biopharmaceutical companies
  11.3.4. Contract research organizations
11.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  11.4.1. Japan
  11.4.2. China
  11.4.3. India
  11.4.4. ASEAN
  11.4.5. Australia & New Zealand
  11.4.6. Rest of Asia-Pacific
11.5. Asia-Pacific Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
11.6. Europe Cell Based Assay Market Dynamics – Trends

12. LATIN AMERICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Consumables
  12.1.2. Assay Kits
  12.1.3. Reagents
  12.1.4. Cell growth assay
  12.1.5. Reporter gene assay
  12.1.6. Immortalized cell lines
  12.1.7. Stem cell lines
  12.1.8. Primary cell lines
  12.1.9. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. ADME studies
  12.2.2. Basic research
  12.2.3. Predictive toxicology
  12.2.4. Drug discovery
  12.2.5. Other
12.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. Diagnostic Centres
  12.3.2. Hospitals
  12.3.3. Biopharmaceutical companies
  12.3.4. Contract research organizations
12.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Brazil
  12.4.2. Mexico
  12.4.3. Argentina
  12.4.4. Venezuela
  12.4.5. Rest of Latin America
12.5. Latin America Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
12.6. Latin America Cell Based Assay Market Dynamics – Trends

13. MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Product Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Consumables
  13.1.2. Assay Kits
  13.1.3. Reagents
  13.1.4. Cell growth assay
  13.1.5. Reporter gene assay
  13.1.6. Immortalized cell lines
  13.1.7. Stem cell lines
  13.1.8. Primary cell lines
  13.1.9. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. ADME studies
  13.2.2. Basic research
  13.2.3. Predictive toxicology
  13.2.4. Drug discovery
  13.2.5. Other
13.3. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. Diagnostic Centres
  13.3.2. Hospitals
  13.3.3. Biopharmaceutical companies
  13.3.4. Contract research organizations
13.4. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.4.1. Gulf Cooperation Council (GCC) Countries
  13.4.2. Israel
  13.4.3. South Africa
  13.4.4. Rest of MEA
13.5. MEA Cell Based Assay Market - Opportunity Analysis Index, By Product Type, By Application, By End-User and Country, 2017 – 2023
13.6. MEA Cell Based Assay Market Dynamics – Trends

14. COMPETITION LANDSCAPE

14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  14.2.1. PerkinElmer Inc. (U.S.)
  14.2.2. GE Healthcare (UK)
  14.2.3. ProQinase GmbH (Germany)
  14.2.4. Danaher Corporation (U.S.)
  14.2.5. Essen BioScience Inc. (U.S.)
  14.2.6. Lonza Group (U.S.)
  14.2.7. Thermo Fisher Scientific Inc. (U.S.)
  14.2.8. Abenex Capital SA (France)
  14.2.9. Axiogenesis AG (Germany)
  14.2.10. Metrion Biosciences Ltd. (UK.)

15. RESEARCH METHODOLOGY

16. KEY ASSUMPTIONS AND ACRONYMS


More Publications